TOVX
TOVX clinical trials: Theriva Biologics, Inc.
Every trial on ClinicalTrials.gov where Theriva Biologics, Inc. is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 9
- Trials linked
- 8
- As lead sponsor
- 1
- As collaborator
- 0
- Primary completions as lead sponsor, next 90 days
TOVX on the catalyst calendar · TOVX registry changes
- Primary completion Sep 30, 2029Sponsor estimatePhase 1/Phase 2NCT04692181SYN-004 Safety and Tolerability in Allo-HCT SubjectsTheriva Biologics, Inc. · Acute Graft-Versus-Host Reaction Following Bone Marrow TransplantActive, not recruitingTOVXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion May 18, 2021ActualPhase 1NCT04815993Pharmacokinetics, Safety, and Tolerability of SYN-020Theriva Biologics, Inc. · Enteritis Caused by Radiation (Disorder)CompletedTOVXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 22, 2022ActualPhase 1NCT05045833Multiple Ascending Dose Study to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered SYN 020Theriva Biologics, Inc. · Enteritis Caused by RadiationCompletedTOVXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 2016ActualPhase 2NCT02563106A Study of SYN-004 for the Prevention of C.Diff in Patients With a LRTITheriva Biologics, Inc. · Clostridium DifficileCompletedTOVXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 2015ActualPhase 2NCT02495623A Study of the Effect of SYN-010 on Subjects With IBS-CTheriva Biologics, Inc. · Irritable Bowel Syndrome With Constipation (IBS-C)CompletedTOVXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 2015ActualPhase 2NCT02493036A Single-Dose, Open-Label, Study to Evaluate the Sustainability of the Effects of SYN-010 in Patients With IBS-CTheriva Biologics, Inc. · Irritable Bowel Syndrome With Constipation (IBS-C)CompletedTOVXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 2016ActualPhase 1/Phase 2NCT02473640A Study Evaluating the Effect of Esomeprazole on SYN-004 Degradation of Ceftriaxone In Adults With an IleostomyTheriva Biologics, Inc. · Healthy Volunteers With IleostomyCompletedTOVXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 2015ActualPhase 1/Phase 2NCT02419001A Study to Evaluate the Effect of SYN-004 on the PK of IV Ceftriaxone in Adults With a Functioning IleostomyTheriva Biologics, Inc. · Healthy VolunteersCompletedTOVXLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 9, 2020ActualPhase 2NCT03763175Efficacy and Safety of SYN-010 in IBS-CCedars-Sinai Medical Center · Irritable Bowel Syndrome With ConstipationTerminatedTOVXCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 9 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScanner